Sources: U.S. Food and Drug Administration (FDA) Compounding and the FDA (503A & 503B guidance) FDA warning letters on unapproved peptide products National Institutes of Health (NIH) PubMed FDA Sends Warning Letters to More Than 50 GLP 1 Compounders and Manufacturers Wilson Sonsini RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals FDA Warns Companies for Illegally Selling Food and Beverage Products that Contain CBD FDA FDA Issues 115 Warning Letters to Retailers Selling Unauthorized E Cigarettes Buchanan Ingersoll & Rooney PC The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York